Wicker Park staple The Violet Hour closed until further notice
The bar, located at 1520 N. Damen Avenue, has already been closed for nearly three weeks due to ongoing plumbing issues and internal repairs needed at the property.
Wicker Park bar named one of the nation's best by Food & Wine
In a statement shared on social media, the owners say they are still in discussions with the building's landlord about how to proceed with the repairs. As a result, the reopening date remains uncertain.
'While we don't have a set timeline yet, it is very much our intention to reach a resolution and make the necessary repairs to the building,' the post read.
The closure comes just ahead of the James Beard Awards, set to take place in Chicago on June 16. The Violet Hour had been scheduled to host a pop-up for Scotch Lodge, a nominated bar from Portland, Oregon.
A new cocktail book from The Violet Hour's Beverage Director
Bar officials say that event has now been moved to Friends of Friends, a newly opened neighborhood bar at 2001 W. Grand Avenue. All existing reservations will be honored at the new venue.
'Thank you for your continued support. We can't wait to welcome you back, if and when the time is right,' The Violet Hour said.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 hours ago
- Yahoo
Tyson Foods Reports Third Quarter 2025 Results
Multi-Protein Portfolio and Operational Focus Fuel Continued Top and Adjusted Bottom-Line Gains SPRINGDALE, Ark., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN), one of the world's largest food companies and a recognized leader in protein with leading brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp and State Fair, reported the following results: (in millions, except per share data) Third Quarter Nine Months Ended 2025 2024 2025 2024 Sales $ 13,884 $ 13,353 $ 40,581 $ 39,744 Operating Income $ 260 $ 341 $ 940 $ 884 Adjusted1 Operating Income (non-GAAP) $ 505 $ 491 $ 1,679 $ 1,308 Net Income Per Share Attributable to Tyson $ 0.17 $ 0.54 $ 1.20 $ 1.25 Adjusted1 Net Income Per Share Attributable to Tyson (non-GAAP) $ 0.91 $ 0.87 $ 2.97 $ 2.18 1 The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). As used in this table and throughout this earnings release, adjusted operating income (loss) and adjusted net income per share attributable to Tyson (Adjusted EPS) are non-GAAP financial measures. Refer to the end of this release for an explanation and reconciliation of these and other non-GAAP financial measures used in this release to comparable GAAP measures. First Nine Months Highlights Sales of $40,581 million, up 2.1% from prior year; legal contingency accruals reduced sales in fiscal 2025 by $343 million, or 0.8% GAAP operating income of $940 million, up 6% from prior year Adjusted operating income of $1,679 million, up 28% from prior year GAAP EPS of $1.20, down 4% from prior year Adjusted EPS of $2.97, up 36% from prior year Total Company GAAP operating margin of 2.3% Total Company adjusted operating margin (non-GAAP) of 4.1% Cash provided by operating activities of $1,620 million, down $353 million from prior year Free cash flow (non-GAAP) of $929 million, down $160 million from prior year Liquidity of $4.0 billion as of June 28, 2025; reduced total debt $722 million Third Quarter Highlights Sales of $13,884 million, up 4.0% from prior year GAAP operating income of $260 million, down 24% from prior year Adjusted operating income of $505 million, up 3% from prior year GAAP EPS of $0.17, down 69% from prior year Adjusted EPS of $0.91, up 5% from prior year Total Company GAAP operating margin of 1.9% Total Company adjusted operating margin (non-GAAP) of 3.6% Recorded a goodwill impairment charge of $343 million in our Beef segment "Our third quarter results demonstrate the strength of our multi-protein, multi-channel portfolio and our relentless focus on operational excellence," said Donnie King, President & CEO of Tyson Foods. "Delivering our fifth consecutive quarter of year-over-year growth across sales, adjusted operating income and adjusted earnings per share underscores the resilience of our business model. Looking ahead, we are confident in our ability to meet consumer needs, capitalize on protein demand and deliver long-term value to our shareholders." SEGMENT RESULTS (in millions) Sales(for the third quarter and nine months ended June 28, 2025, and June 29, 2024) Third Quarter Nine Months Ended 2025 2024 VolumeChange Avg. PriceChange2 2025 2024 VolumeChange Avg. PriceChange2 Beef $ 5,603 $ 5,241 (3.1 )% 10.0 % $ 16,134 $ 15,218 0.3 % 6.3 % Pork 1,506 1,462 1.5 % (1.6 )% 4,367 4,465 (1.0 )% 3.4 % Chicken 4,220 4,076 2.4 % 1.1 % 12,426 12,174 2.3 % (0.2 )% Prepared Foods 2,515 2,432 (2.3 )% 5.7 % 7,384 7,379 (2.7 )% 2.8 % International/Other 557 582 (0.8 )% (3.5 )% 1,707 1,744 0.7 % (2.8 )% Intersegment Sales (517 ) (440 ) n/a n/a (1,437 ) (1,236 ) n/a n/a Total $ 13,884 $ 13,353 (0.1 )% 3.7 % $ 40,581 $ 39,744 0.5 % 2.4 % Operating Income (Loss)(for the third quarter and nine months ended June 28, 2025, and June 29, 2024) Third Quarter Nine Months Ended Operating Margin Operating Margin 2025 2024 2025 2024 2025 2024 2025 2024 Beef $ (494 ) $ (69 ) (8.8 )% (1.3 )% $ (816 ) $ (310 ) (5.1 )% (2.0 )% Pork 36 (62 ) 2.4 % (4.2 )% (100 ) (24 ) (2.3 )% (0.5 )% Chicken 367 244 8.7 % 6.0 % 980 579 7.9 % 4.8 % Prepared Foods 302 203 12.0 % 8.3 % 755 676 10.2 % 9.2 % International/Other 49 25 n/a n/a 121 (37 ) n/a n/a Total $ 260 $ 341 1.9 % 2.6 % $ 940 $ 884 2.3 % 2.2 % ADJUSTED SEGMENT RESULTS (in millions) Adjusted Operating Income (Loss) (Non-GAAP)1(for the third quarter and nine months ended June 28, 2025, and June 29, 2024) Third Quarter Nine Months Ended Adjusted OperatingMargin (Non-GAAP) Adjusted OperatingMargin (Non-GAAP) 2025 2024 2025 20242 2025 2024 20252 20242 Beef $ (151 ) $ (69 ) (2.7 )% (1.3 )% $ (332 ) $ (220 ) (2.0 )% (1.4 )% Pork 36 22 2.4 % 1.5 % 150 123 3.2 % 2.7 % Chicken 345 307 8.2 % 7.5 % 1,025 659 8.2 % 5.4 % Prepared Foods 246 203 9.8 % 8.3 % 724 700 9.8 % 9.5 % International/Other 29 28 n/a n/a 112 46 n/a n/a Total $ 505 $ 491 3.6 % 3.7 % $ 1,679 $ 1,308 4.1 % 3.3 % 2 Average Price Change and Adjusted Operating Margin (Non-GAAP) for the Beef and Pork segments and Total Company for the nine months ended June 28, 2025 exclude the impact of $93 million, $250 million and $343 million, respectively, of legal contingency accruals recognized as reductions to Sales. Average Price Change and Adjusted Operating Margin (Non-GAAP) for the Pork segment and Total Company for the three and nine months ended June 29, 2024 exclude the impact of $45 million of legal contingency accruals recognized as reductions to sales. OUTLOOKFor fiscal 2025, the United States Department of Agriculture (USDA) indicates domestic protein production (beef, pork, chicken and turkey) will be relatively flat compared to fiscal 2024 levels. The following is a summary of the updated outlook for each of our segments, as well as an outlook for revenue, capital expenditures, net interest expense, liquidity, free cash flow and tax rate for fiscal 2025. Certain of the outlook numbers include adjusted operating income (loss) (a non-GAAP metric) for each segment. The Company is not able to reconcile its full-year fiscal 2025 projected adjusted results to its fiscal 2025 projected GAAP results because certain information necessary to calculate such measures on a GAAP basis is unavailable or dependent on the timing of future events outside of our control. Therefore, because of the uncertainty and variability of the nature of and the amount of any potential applicable future adjustments, which could be significant, the Company is unable to provide a reconciliation for these forward-looking non-GAAP measures without unreasonable effort. Adjusted operating income (loss) should not be considered a substitute for operating income (loss) or any other measures of financial performance reported in accordance with GAAP. Investors should rely primarily on the Company's GAAP results and use non-GAAP financial measures only supplementally in making investment decisions. BeefUSDA projects domestic production will decrease approximately 2% in fiscal 2025 as compared to fiscal 2024. We anticipate adjusted operating loss between $(475) million to $(375) million in fiscal 2025. PorkUSDA projects domestic production will increase slightly in fiscal 2025 as compared to fiscal 2024. We anticipate adjusted operating income of $175 million to $200 million in fiscal 2025. ChickenUSDA projects chicken production will increase approximately 2% in fiscal 2025 as compared to fiscal 2024. We anticipate adjusted operating income of $1.3 billion to $1.4 billion for fiscal 2025. Prepared FoodsWe anticipate adjusted operating income of $925 million to $1.0 billion in fiscal 2025. International/OtherWe anticipate improved results from our foreign operations in fiscal 2025 on an adjusted basis. Total CompanyWe anticipate total company adjusted operating income of $2.1 billion to $2.3 billion for fiscal 2025. RevenueWe expect sales to be up 2% to 3% in fiscal 2025 as compared to fiscal 2024. Capital ExpendituresWe expect capital expenditures at or below $1.0 billion for fiscal 2025. Capital expenditures include investments in profit improvement projects as well as projects for maintenance and repair. Net Interest ExpenseWe expect net interest expense to approximate $375 million for fiscal 2025. LiquidityWe expect total liquidity, which was $4.0 billion as of June 28, 2025, to remain above our minimum liquidity target of $1.0 billion. Free Cash FlowWe expect free cash flow to be between $1.0 billion and $1.3 billion for fiscal 2025. Tax RateWe currently expect our adjusted effective tax rate to approximate 25% for fiscal 2025. TYSON FOODS, CONDENSED STATEMENTS OF INCOME(In millions, except per share data)(Unaudited) Three Months Ended Nine Months Ended June 28, 2025 June 29, 2024 June 28, 2025 June 29, 2024 Sales $ 13,884 $ 13,353 $ 40,581 $ 39,744 Cost of Sales 12,743 12,475 37,745 37,177 Gross Profit 1,141 878 2,836 2,567 Selling, General and Administrative 538 537 1,553 1,683 Goodwill Impairment 343 — 343 — Operating Income 260 341 940 884 Other (Income) Expense: Interest income (15 ) (36 ) (57 ) (60 ) Interest expense 113 135 343 351 Other, net (31 ) (11 ) (47 ) (24 ) Total Other (Income) Expense 67 88 239 267 Income before Income Taxes 193 253 701 617 Income Tax Expense 124 57 252 159 Net Income 69 196 449 458 Less: Net Income Attributable to Noncontrolling Interests 8 5 22 15 Net Income Attributable to Tyson $ 61 $ 191 $ 427 $ 443 Net Income Per Share Attributable to Tyson: Class A Basic $ 0.18 $ 0.55 $ 1.23 $ 1.28 Class B Basic $ 0.16 $ 0.49 $ 1.10 $ 1.14 Diluted $ 0.17 $ 0.54 $ 1.20 $ 1.25 Dividends Declared Per Share: Class A $ 0.500 $ 0.490 $ 1.510 $ 1.480 Class B $ 0.450 $ 0.441 $ 1.359 $ 1.332 Sales Growth 4.0 % 2.1 % Margins: (Percent of Sales) Gross Profit 8.2 % 6.6 % 7.0 % 6.5 % Operating Income 1.9 % 2.6 % 2.3 % 2.2 % Net Income Attributable to Tyson 0.4 % 1.4 % 1.1 % 1.1 % Effective Tax Rate3 64.5 % 22.9 % 36.0 % 25.9 % 3 The effective tax rate for the three and nine months ended June 28, 2025 is impacted by a $343 million goodwill impairment as the impairment charge is non-deductible for income tax purposes. TYSON FOODS, CONDENSED BALANCE SHEETS(In millions)(Unaudited) June 28, 2025 September 28, 2024 Assets Current Assets: Cash and cash equivalents $ 1,547 $ 1,717 Accounts receivable, net 2,454 2,406 Inventories 5,436 5,195 Other current assets 422 433 Total Current Assets 9,859 9,751 Net Property, Plant and Equipment 9,081 9,442 Goodwill 9,468 9,819 Intangible Assets, net 5,683 5,875 Other Assets 2,373 2,213 Total Assets $ 36,464 $ 37,100 Liabilities and Shareholders' Equity Current Liabilities: Current debt $ 886 $ 74 Accounts payable 2,373 2,402 Other current liabilities 2,431 2,311 Total Current Liabilities 5,690 4,787 Long-Term Debt 8,179 9,713 Deferred Income Taxes 2,217 2,285 Other Liabilities 1,910 1,801 Total Tyson Shareholders' Equity 18,338 18,390 Noncontrolling Interests 130 124 Total Shareholders' Equity 18,468 18,514 Total Liabilities and Shareholders' Equity $ 36,464 $ 37,100 TYSON FOODS, CONDENSED STATEMENTS OF CASH FLOWS(In millions)(Unaudited) Nine Months Ended June 28, 2025 June 29, 2024 Cash Flows From Operating Activities: Net income $ 449 $ 458 Depreciation and amortization 1,029 1,082 Deferred income taxes (61 ) 6 Impairment of goodwill 343 — Gain on sale of storage facilities (107 ) — Other, net 158 162 Net changes in operating assets and liabilities (191 ) 265 Cash Provided by Operating Activities 1,620 1,973 Cash Flows From Investing Activities: Additions to property, plant and equipment (691 ) (884 ) Purchases of marketable securities (50 ) (23 ) Proceeds from sale of marketable securities 47 21 Proceeds from sale of storage facilities 252 — Acquisition of equity investments (5 ) (28 ) Other, net 42 60 Cash Used for Investing Activities (405 ) (854 ) Cash Flows From Financing Activities: Proceeds from issuance of debt 63 2,391 Payments on debt (876 ) (347 ) Proceeds from issuance of commercial paper — 1,649 Repayments of commercial paper — (2,240 ) Purchases of Tyson Class A common stock (42 ) (44 ) Dividends (524 ) (513 ) Stock options exercised 20 9 Other, net (18 ) (22 ) Cash (Used for) Provided by Financing Activities (1,377 ) 883 Effect of Exchange Rate Changes on Cash (8 ) (6 ) (Decrease) Increase in Cash and Cash Equivalents and Restricted Cash (170 ) 1,996 Cash and Cash Equivalents and Restricted Cash at Beginning of Year 1,717 573 Cash and Cash Equivalents and Restricted Cash at End of Period 1,547 2,569 Less: Restricted Cash at End of Period — — Cash and Cash Equivalents at End of Period $ 1,547 $ 2,569 Non-GAAP Financial Measures Adjusted Operating Income (Loss), Adjusted Income before Income Taxes, Adjusted Income Tax Expense, Adjusted Net Income Attributable to Tyson and Adjusted EPS, EBITDA, Adjusted EBITDA, net debt to EBITDA, net debt to Adjusted EBITDA and Free Cash Flow are presented as supplemental financial measures in the evaluation of our business that are not required by, or presented in accordance with GAAP. The non-GAAP financial measures are tools intended to assist our management and investors in comparing our performance on a consistent basis for purposes of business decision-making by removing the impact of certain items that management believes do not directly reflect our core operations on an ongoing basis. These non-GAAP measures should not be a substitute for their comparable GAAP financial measures. Investors should rely primarily on our GAAP results and use non-GAAP financial measures only supplementally in making investment decisions. We believe the presentation of these non-GAAP financial measures helps management and investors to assess our operating performance from period to period, including our ability to generate earnings sufficient to service our debt, enhances understanding of our financial performance and highlights operational trends. These measures are widely used by investors and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Our calculation of non-GAAP measures may not be comparable to similarly titled measures reported by other companies and other companies may not define these non-GAAP financial measures in the same way, which may limit their usefulness of comparative measures. Definitions is defined as net income before interest, income taxes, depreciation and amortization. Net debt to EBITDA (Adjusted EBITDA) represents the ratio of our debt, net of cash, cash equivalents and short-term investments, to EBITDA (and to Adjusted EBITDA). EBITDA, Adjusted EBITDA, net debt to EBITDA and net debt to Adjusted EBITDA are presented as supplemental financial measurements in the evaluation of our business. are defined as EBITDA, Operating Income (Loss), Income before Income Taxes, Income Tax Expense, Net Income Attributable to Tyson and diluted earnings per share, respectively, excluding the impacts of any items that management believes do not directly reflect our core operations on an ongoing basis. is defined as Cash Provided by Operating Activities minus payments for Property, Plant and Equipment. TYSON FOODS, Results to Non-GAAP Results Reconciliations(In millions, except per share data)(Unaudited) Results for the third quarter ended June 28, 2025 Sales Cost ofSales Selling,General andAdministrative Goodwill Impairment Operating Income Other(Income)Expense Income before Income Taxes Income TaxExpense Net IncomeAttributable toTyson EPSImpact GAAP Results $ 260 $ 193 $ 124 $ 61 $ 0.17 Brand discontinuation — — 5 — 5 — 5 1 4 0.01 Network optimization plan6 — (83 ) — — (83 ) — (83 ) (18 ) (65 ) (0.18 ) The Netherlands facility7 — (14 ) — — (14 ) — (14 ) — (14 ) (0.04 ) China plant relocationremuneration8 — (6 ) — — (6 ) — (6 ) (1 ) (4 ) (0.01 ) Goodwill impairment9 — — — 343 343 — 343 — 343 0.96 Adjusted Non-GAAP Results $ 505 $ 438 $ 106 $ 325 $ 0.91 Results for the third quarter ended June 29, 2024 Sales Cost ofSales Selling,General and Administrative Goodwill Impairment Operating Income Other(Income) Expense Income before Income Taxes Income TaxExpense Net IncomeAttributable toTyson EPSImpact GAAP Results $ 341 $ 253 $ 57 $ 191 $ 0.54 Production facility fire costs incurred,net of insurance proceeds5 — 5 — — 5 — 5 1 4 0.01 The Netherlands facility7 — 3 — — 3 — 3 — 3 0.01 Plant closures and disposals — 41 — — 41 — 41 8 33 0.09 Legal contingency accruals 45 56 — — 101 — 101 23 78 0.22 Adjusted Non-GAAP Results $ 491 $ 403 $ 89 $ 309 $ 0.87 Results for the nine months ended June 28, 2025 Sales Cost ofSales Selling,General andAdministrative GoodwillImpairment OperatingIncome Other(Income)Expense Income beforeIncome Taxes Income TaxExpense Net IncomeAttributable toTyson EPSImpact GAAP Results $ 940 $ 701 $ 252 $ 427 $ 1.20 Production facility fire insuranceproceeds, net of costs incurred5 — — — — — (7 ) (7 ) (2 ) (5 ) (0.01 ) Brand discontinuation — — 17 — 17 — 17 4 13 0.04 Network optimization plan6 — 31 2 — 33 — 33 4 29 0.08 The Netherlands facility7 — (14 ) — — (14 ) — (14 ) 9 (23 ) (0.07 ) Legal contingency accruals 343 — — — 343 — 343 81 262 0.73 Plant closures and disposals — 23 — — 23 — 23 6 17 0.05 China plant relocationremuneration8 — (6 ) — — (6 ) — (6 ) (1 ) (4 ) (0.01 ) Goodwill Impairment9 — — — 343 343 — 343 — 343 0.96 Adjusted Non-GAAP Results $ 1,679 $ 1,433 $ 353 $ 1,059 $ 2.97 Results for the nine months ended June 29, 2024 Sales Cost ofSales Selling,General andAdministrative GoodwillImpairment OperatingIncome Other(Income)Expense Income beforeIncome Taxes Income TaxExpense Net IncomeAttributable toTyson EPSImpact GAAP Results $ 884 $ 617 $ 159 $ 443 $ 1.25 Production facility fire insuranceproceeds, net of costs incurred5 — (19 ) — — (19 ) (3 ) (22 ) (5 ) (17 ) (0.05 ) The Netherlands facility7 — 83 — — 83 — 83 — 83 0.23 Restructuring and relatedcharges — — 31 — 31 — 31 8 23 0.06 Plant closures and disposals — 155 — — 155 — 155 46 109 0.31 Legal contingency accruals 45 129 — — 174 — 174 41 133 0.38 Adjusted Non-GAAP Results $ 1,308 $ 1,038 $ 249 $ 774 $ 2.18 TYSON FOODS, Operating Income (Loss) Non-GAAP Reconciliations(In millions)(Unaudited) Adjusted Operating Income (Loss)(for the third quarter ended June 28, 2025) Beef Pork Chicken PreparedFoods International/Other Total Reported operating income (loss) $ (494 ) $ 36 $ 367 $ 302 $ 49 $ 260 Add: Brand discontinuation — — 5 — — 5 Less: Network optimization plan6 — — (27 ) (56 ) — (83 ) Less: The Netherlands facility7 — — — — (14 ) (14 ) Less: China plant relocation remuneration — — — — (6 ) (6 ) Add: Goodwill impairment 343 — — — — 343 Adjusted operating income (loss) $ (151 ) $ 36 $ 345 $ 246 $ 29 $ 505 Adjusted Operating Income (Loss)(for the third quarter ended June 29, 2024) Beef Pork Chicken PreparedFoods International/Other Total Reported operating income (loss) $ (69 ) $ (62 ) $ 244 $ 203 $ 25 $ 341 Add: Production facility fire costs incurred, net ofinsurance proceeds5 — — 5 — — 5 Add: The Netherlands facility7 — — — — 3 3 Add: Plant closures and disposals — 39 2 — — 41 Add: Legal contingency accruals — 45 56 — — 101 Adjusted operating income (loss) $ (69 ) $ 22 $ 307 $ 203 $ 28 $ 491 Adjusted Operating Income (Loss)(for the nine months ended June 28, 2025) Beef Pork Chicken PreparedFoods International/Other Total Reported operating income (loss) $ (816 ) $ (100 ) $ 980 $ 755 $ 121 $ 940 Add: Brand discontinuation — — 17 — — 17 Add/(Less): Network optimization plan6 48 — 5 (31 ) 11 33 Less: The Netherlands facility7 — — — — (14 ) (14 ) Add: Legal contingency accruals 93 250 — — — 343 Add: Plant closures and disposals — — 23 — — 23 Less: China plant relocation remuneration — — — — (6 ) (6 ) Add: Goodwill impairment 343 — — — — 343 Adjusted operating income (loss) $ (332 ) $ 150 $ 1,025 $ 724 $ 112 $ 1,679 Adjusted Operating Income (Loss)(for the nine months ended June 29, 2024) Beef Pork Chicken PreparedFoods International/Other Total Reported operating income (loss) $ (310 ) $ (24 ) $ 579 $ 676 $ (37 ) $ 884 Less: Production facility fire insurance proceeds,net of costs incurred5 — — (19 ) — — (19 ) Add: The Netherlands facility7 — — — — 83 83 Add: Restructuring and related charges 4 1 2 24 — 31 Add: Plant closures and disposals 41 73 41 — — 155 Add: Legal contingency accruals 45 73 56 — — 174 Adjusted operating income (loss) $ (220 ) $ 123 $ 659 $ 700 $ 46 $ 1,308 TYSON FOODS, and Adjusted EBITDA Non-GAAP Reconciliations(In millions)(Unaudited) Nine Months Ended Fiscal Year Ended Twelve Months Ended June 28, 2025 June 29, 2024 September 28, 2024 June 28, 2025 Net income $ 449 $ 458 $ 822 $ 813 Less: Interest income (57 ) (60 ) (89 ) (86 ) Add: Interest expense 343 351 481 473 Add: Income tax expense 252 159 270 363 Add: Depreciation 828 902 1,159 1,085 Add: Amortization4 193 171 229 251 EBITDA $ 2,008 $ 1,981 $ 2,872 $ 2,899 Adjustments to EBITDA: Less: Production facility fire insuranceproceeds, net of costs incurred5 $ (7 ) $ (22 ) $ (104 ) $ (89 ) Add: Brand discontinuation 17 — 8 25 Add: Network optimization plan6 33 — — 33 Add/(Less): The Netherlands facility7 (14 ) 83 86 (11 ) Add: Legal contingency accruals 343 174 174 343 Add: Plant closures and disposals 23 155 182 50 Less: China plant relocation remuneration (6 ) — — (6 ) Add: Goodwill impairment 343 — — 343 Add: Restructuring and related charges — 31 31 — Less: Depreciation and amortization includedin EBITDA adjustments10 (56 ) (127 ) (129 ) (58 ) Total Adjusted EBITDA $ 2,684 $ 2,275 $ 3,120 $ 3,529 Total gross debt $ 9,787 $ 9,065 Less: Cash and cash equivalents (1,717 ) (1,547 ) Less: Short-term investments (10 ) (1 ) Total net debt $ 8,060 $ 7,517 Ratio Calculations: Gross debt/EBITDA 3.4 x 3.1 x Net debt/EBITDA 2.8 x 2.6 x Gross debt/Adjusted EBITDA 3.1 x 2.6 x Net debt/Adjusted EBITDA 2.6 x 2.1 x 4 Excludes the amortization of debt issuance and debt discount expense of $8 million for the nine months ended June 28, 2025, $9 million for the nine months ended June 29, 2024, $12 million for the fiscal year ended September 28, 2024 and $11 million for the twelve months ended June 28, 2025 as it is included in interest expense. 5 Relates to a fire at a Chicken production facility in the fourth quarter of fiscal 2021. 6 Includes gain on sale of storage facilities in the third quarter of fiscal 2025. 7 Includes insurance recoveries and charges related to a fire at our production facility in the Netherlands in the first quarter of fiscal 2024 and subsequent decision to sell the facility. 8 The China plant relocation remuneration EPS impact is net of $1 million associated with Net Income (Loss) Attributable to Noncontrolling Interests. 9 Goodwill impairment is non-deductible for income tax purposes. 10 Removal of accelerated depreciation of $39 million related to network optimization plan charges for the nine and twelve months ended June 28, 2025 and $127 million related to plant closures and disposals for the nine months ended June 29, 2024 and twelve months ended September 28, 2024 as they are already included in depreciation expense. Removal of accelerated amortization of $17 million, $2 million and $19 million related to brand discontinuation for the nine months ended June 28, 2025, the twelve months ended September 28, 2024 and the twelve months ended June 28, 2025, respectively, as they are already included in amortization expense. TYSON FOODS, Cash Flow Non-GAAP Reconciliation(In millions)(Unaudited) Nine Months Ended June 28, 2025 June 29, 2024 Cash Provided by Operating Activities $ 1,620 $ 1,973 Additions to property, plant and equipment (691 ) (884 ) Free cash flow $ 929 $ 1,089 About Tyson Foods, Foods, Inc. (NYSE: TSN) is a world-class food company and recognized leader in protein. Founded in 1935 by John W. Tyson, it has grown under four generations of family leadership. The Company is unified by this purpose: Tyson Foods. We Feed the World Like Family™ and has a broad portfolio of iconic products and brands including Tyson®, Jimmy Dean®, Hillshire Farm®, Ball Park®, Wright®, State Fair®, Aidells® and ibp®. Tyson Foods is dedicated to bringing high-quality food to every table in the world, safely, sustainably, and affordably, now and for future generations. Headquartered in Springdale, Arkansas, the company had approximately 138,000 team members on September 28, 2024. Visit Conference Call Information and Other Selected DataA conference call to discuss the Company's financial results will be held at 9 a.m. Eastern Monday, August 4, 2025. A link for the webcast of the conference call is available on the Tyson Investor Relations website at The webcast also can be accessed by the following direct link: For those who cannot participate at the scheduled time, a replay of the live webcast and the accompanying slides will be available at A telephone replay will also be available until September 4, 2025, toll free at 1-877-344-7529, international toll 1-412-317-0088 or Canada toll free 855-669-9658. The replay access code is 4590866. Financial information, such as this news release, as well as other supplemental data, can be accessed from the Company's web site at Forward-Looking StatementsCertain information in this release constitutes forward-looking statements as contemplated by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, current views and estimates of our outlook for fiscal 2025, other future economic circumstances, industry conditions in domestic and international markets, our performance and financial results (e.g., debt levels, return on invested capital, value-added product growth, capital expenditures, tax rates, access to foreign markets and dividend policy). These forward-looking statements are subject to a number of factors and uncertainties that could cause our actual results and experiences to differ materially from anticipated results and expectations expressed in such forward-looking statements. We wish to caution readers not to place undue reliance on any forward-looking statements, which are expressly qualified in their entirety by this cautionary statement and speak only as of the date made. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that may cause actual results and experiences to differ from anticipated results and expectations expressed in such forward-looking statements are the following: (i) global pandemics have had, and may in the future have, an adverse impact on our business and operations; (ii) the effectiveness of financial excellence programs; (iii) access to, and inputs from, foreign markets together with foreign economic conditions, including currency fluctuations, import/export restrictions and foreign politics; (iv) cyber attacks, other cyber incidents, security breaches or other disruptions of our information technology systems; (v) risks associated with our failure to consummate favorable acquisition transactions or integrate certain acquisitions' operations; (vi) the Tyson Limited Partnership's ability to exercise significant control over the Company; (vii) fluctuations in the cost and availability of inputs and raw materials, such as live cattle, live swine, feed grains (including corn and soybean meal) and energy; (viii) market conditions for finished products, including competition from other global and domestic food processors, supply and pricing of competing products and alternative proteins and demand for alternative proteins; (ix) outbreak of a livestock disease (such as African swine fever (ASF), avian influenza (AI) or bovine spongiform encephalopathy (BSE)), which could have an adverse effect on livestock we own, the availability of livestock we purchase, consumer perception of certain protein products or our ability to conduct our operations; (x) changes in consumer preference and diets and our ability to identify and react to consumer trends; (xi) effectiveness of advertising and marketing programs; (xii) significant marketing plan changes by large customers or loss of one or more large customers; (xiii) our ability to leverage brand value propositions; (xiv) changes in availability and relative costs of labor and contract farmers and our ability to maintain good relationships with team members, labor unions, contract farmers and independent producers providing us livestock; (xv) issues related to food safety, including costs resulting from product recalls, regulatory compliance and any related claims or litigation; (xvi) compliance with and changes to regulations and laws (both domestic and foreign), including changes in accounting standards, tax laws, environmental laws, agricultural laws and occupational, health and safety laws; (xvii) the effect of climate change and any legal or regulatory response thereto; (xviii) adverse results from litigation; (xix) risks associated with leverage, including cost increases due to rising interest rates or changes in debt ratings or outlook; (xx) impairment in the carrying value of our goodwill or indefinite life intangible assets; (xxi) our participation in a multiemployer pension plan; (xxii) volatility in capital markets or interest rates; (xxiii) risks associated with our commodity purchasing activities; (xxiv) the effect of, or changes in, general economic conditions; (xxv) impacts on our operations caused by factors and forces beyond our control, such as natural disasters, fire, bioterrorism, pandemics, armed conflicts or extreme weather; (xxvi) failure to maximize or assert our intellectual property rights; (xxvii) effects related to changes in tax rates, valuation of deferred tax assets and liabilities, or tax laws and their interpretation; and (xxviii) the other risks and uncertainties detailed from time to time in our filings with the Securities and Exchange Commission, including those included under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our most recent Annual Report on Form 10-K and Quarterly reports on Form 10-Q. Media Contact: Laura Burns, 479-713-9890Investor Contact: Sean Cornett, 479-466-0401 Source: Tyson Foods, IR, NewsroomSign in to access your portfolio
Bloomberg
a day ago
- Bloomberg
Japanese Food Exports in First Half of 2025 Hit Record High
Japanese food exports in the first six months of 2025 hit a record high of ¥809.7 billion ($5.5 billion) according to the agriculture ministry. The record figures were pushed up in part by a 22% increase in exports to the US from a year earlier, as focus intensifies on the implementation of a US trade deal agreed last week aimed at closing the trade gap between the two countries.
Yahoo
a day ago
- Yahoo
Carry Wealth Holdings Leads The Charge In Asian Penny Stocks
Amidst a backdrop of global economic uncertainty, Asian markets have been navigating the complexities of trade tensions and fluctuating economic data. In such times, investors often look beyond established giants to explore opportunities in smaller or newer companies, sometimes referred to as penny stocks. Although the term may seem outdated, these stocks can still present valuable opportunities when backed by strong financials and growth potential. This article explores three Asian penny stocks that stand out for their balance sheet resilience and potential for significant returns. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.10 THB4.05B ★★★★★☆ Lever Style (SEHK:1346) HK$1.48 HK$933.81M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.39 HK$1.99B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.515 SGD208.72M ★★★★★☆ T.A.C. Consumer (SET:TACC) THB4.66 THB2.8B ★★★★★★ China Sunsine Chemical Holdings (SGX:QES) SGD0.73 SGD695.97M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.53 SGD9.96B ★★★★★☆ Livestock Improvement (NZSE:LIC) NZ$1.00 NZ$142.34M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.70 THB9.5B ★★★★★★ BRC Asia (SGX:BEC) SGD3.57 SGD979.43M ★★★★★★ Click here to see the full list of 987 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. Carry Wealth Holdings Simply Wall St Financial Health Rating: ★★★★★★ Overview: Carry Wealth Holdings Limited is an investment holding company that manufactures, trades, and markets garment products for various brands across the United States, Mainland China, Europe, Hong Kong, and internationally with a market cap of HK$431.93 million. Operations: The company's revenue is primarily derived from its Garment Manufacturing and Trading segment, which generated HK$664.69 million. Market Cap: HK$431.93M Carry Wealth Holdings Limited, with a market cap of HK$431.93 million, primarily generates revenue from its Garment Manufacturing and Trading segment. Despite being unprofitable, the company is debt-free and maintains a strong cash runway exceeding three years based on current free cash flow. Recent board changes introduced experienced financial professionals, potentially strengthening oversight. However, high share price volatility persists alongside negative return on equity at -22.85%. While short-term assets comfortably cover liabilities, both management and board tenures are relatively short, indicating an evolving leadership team as the company navigates its challenges in the competitive garment industry. Jump into the full analysis health report here for a deeper understanding of Carry Wealth Holdings. Review our historical performance report to gain insights into Carry Wealth Holdings' track record. Qinghai Spring Medicinal Resources Technology Simply Wall St Financial Health Rating: ★★★★★★ Overview: Qinghai Spring Medicinal Resources Technology Co., Ltd. operates in the medicinal resources sector and has a market cap of approximately CN¥25.01 billion. Operations: Qinghai Spring Medicinal Resources Technology Co., Ltd. has not reported specific revenue segments. Market Cap: CN¥2.5B Qinghai Spring Medicinal Resources Technology, with a market cap of CN¥25.01 billion, operates without significant revenue streams, indicating it may be pre-revenue. The company is debt-free and possesses a robust cash runway exceeding three years based on current free cash flow. Despite its unprofitability and negative return on equity at -15.54%, the management team and board are experienced, averaging tenures of 10.4 and 5.7 years respectively. Short-term assets significantly exceed liabilities, providing financial stability amidst challenges in achieving profitability as earnings have declined by 8.5% annually over the past five years. Navigate through the intricacies of Qinghai Spring Medicinal Resources Technology with our comprehensive balance sheet health report here. Learn about Qinghai Spring Medicinal Resources Technology's historical performance here. Zhejiang CONBA PharmaceuticalLtd Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang CONBA Pharmaceutical Co., Ltd. focuses on the research, development, production, and sales of pharmaceuticals and health products in mainland China, with a market cap of CN¥11.53 billion. Operations: The company's revenue is primarily generated from its operations in China, amounting to CN¥6.38 billion. Market Cap: CN¥11.53B Zhejiang CONBA Pharmaceutical Co., Ltd. has shown financial resilience with a significant reduction in its debt to equity ratio from 63.8% to 3.9% over five years, and its short-term assets of CN¥4.5 billion comfortably cover both short and long-term liabilities. Despite a low return on equity at 8.7%, the company has maintained stable earnings growth, surpassing industry averages with a recent annual increase of 13.8%. However, its dividend track record remains unstable, and the board's average tenure of 1.6 years suggests limited experience in navigating market complexities effectively. Click here to discover the nuances of Zhejiang CONBA PharmaceuticalLtd with our detailed analytical financial health report. Assess Zhejiang CONBA PharmaceuticalLtd's previous results with our detailed historical performance reports. Make It Happen Explore the 987 names from our Asian Penny Stocks screener here. Curious About Other Options? Rare earth metals are the new gold rush. Find out which 25 stocks are leading the charge. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:643 SHSE:600381 and SHSE:600572. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
